Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(26 sites)

United States

Praxis Research Site, Phoenix, Arizona

Praxis Research Site, DeLand, Florida

Praxis Research Site, Miami Lakes, Florida

Praxis Research Site, Chicago, Illinois

Praxis Research Site, Lafayette, Louisiana

Praxis Research Site, Bethesda, Maryland

Praxis Research Site, Chesterfield, Missouri

Praxis Research Site, Ozark, Missouri

Praxis Research Site, Hackensack, New Jersey

Praxis Research Site, Middletown, New York

Praxis Research Site, Canton, Ohio

Praxis Research Site, Oklahoma City, Oklahoma

Praxis Research Site, El Paso, Texas

Praxis Research Site, Frisco, Texas

Praxis Research Site, Round Rock, Texas

Praxis Research Site, Seabrook, Texas

Spain

Praxis Research Site, Barcelona

Praxis Research Site, Granda

Praxis Research Site, Madrid

Praxis Research Site, Málaga

Praxis Research Site, Terrassa

Praxis Research Site, Valencia